- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
AstraZeneca's top products based on revenue 2015-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
AstraZeneca's top products based on revenue 2015-2018
Top products of AstraZeneca based on revenue from 2015 to 2018 (in million U.S. dollars)
by Matej Mikulic,
last edited
Aug 27, 2019
AstraZeneca is a global biopharmaceutical company with several leading pharmaceutical products. As of 2018, AstraZeneca’s top pharmaceutical product by revenue was Symbicort, an inhaler used in the treatment of asthma and COPD. During that year Symbicort generated about 2.6 billion U.S. dollars in revenue for the company. The second-highest revenue generator for AstraZeneca in the same year was Nexium, a drug used in the treatment of acid reflux disease. Nexium generated about 1.7 billion U.S. dollars in revenue during that year.
AstraZeneca company profile
AstraZeneca is a global pharmaceutical company with many employees all over the world. As of 2018, the highest proportion of AstraZeneca’s employees were based in the Asia-Pacific region. The global office and corporate headquarters of AstraZeneca is located in Cambridge in the United Kingdom. As of 2018, emerging markets and the U.S. market accounted for the highest revenues for AstraZeneca. The company is a leader in research and development globally as well.
AstraZeneca’s R&D
AstraZeneca has many research and development programs that are focused on addressing three main areas, oncology, cardiovascular, renal and metabolic diseases, and respiratory disease. AstraZeneca’s research and development expenditures have increased in recent years. In 2018, 28.2 percent of AstraZeneca’s total revenue was expended on research and development. And, as of early 2019, AstraZeneca was projected to be among the world’s top five pharmaceutical companies according to the number of drugs they had under development at that time.
Top products of AstraZeneca based on revenue from 2015 to 2018 (in million U.S. dollars)
| 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Aug 27, 2019
AstraZeneca is a global biopharmaceutical company with several leading pharmaceutical products. As of 2018, AstraZeneca’s top pharmaceutical product by revenue was Symbicort, an inhaler used in the treatment of asthma and COPD. During that year Symbicort generated about 2.6 billion U.S. dollars in revenue for the company. The second-highest revenue generator for AstraZeneca in the same year was Nexium, a drug used in the treatment of acid reflux disease. Nexium generated about 1.7 billion U.S. dollars in revenue during that year.
AstraZeneca company profile
AstraZeneca is a global pharmaceutical company with many employees all over the world. As of 2018, the highest proportion of AstraZeneca’s employees were based in the Asia-Pacific region. The global office and corporate headquarters of AstraZeneca is located in Cambridge in the United Kingdom. As of 2018, emerging markets and the U.S. market accounted for the highest revenues for AstraZeneca. The company is a leader in research and development globally as well.
AstraZeneca’s R&D
AstraZeneca has many research and development programs that are focused on addressing three main areas, oncology, cardiovascular, renal and metabolic diseases, and respiratory disease. AstraZeneca’s research and development expenditures have increased in recent years. In 2018, 28.2 percent of AstraZeneca’s total revenue was expended on research and development. And, as of early 2019, AstraZeneca was projected to be among the world’s top five pharmaceutical companies according to the number of drugs they had under development at that time.
- Show sources information
- Show publisher information
- Release date
- March 2019
- Region
- Worldwide
- Survey time period
- 2015 to 2018
- Supplementary notes
- This statistic was assembled from several editions of AstraZeneca's annual reports.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- March 2019
More information
- Region
- Worldwide
- Survey time period
- 2015 to 2018
- Supplementary notes
- This statistic was assembled from several editions of AstraZeneca's annual reports.
- Open this statistic in...
Other statistics on the topic
Pharmaceutical Products & Market
Top pharmaceutical products by sales worldwide 2018
+Pharmaceutical Products & Market
AstraZeneca's revenue from top product Nexium 2006-2018
+Pharmaceutical Products & Market
AstraZeneca's revenue from top product Crestor 2006-2018
+Cosmetics & Personal Care
Sales growth of leading antacid tablet brands in the U.S. 2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Pharmaceutical brands: Crestor and Nexium (AstraZeneca)
- 38 page/s
- English
- pptx
- Detailed references
Everything On "Pharmaceutical brands: Crestor and Nexium (AstraZeneca)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Pharmaceutical brands: Crestor and Nexium (AstraZeneca)"
- Overview
The most important statistics
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2018
- Top products of AstraZeneca based on revenue from 2015 to 2018 (in million U.S. dollars)AstraZeneca's top products based on revenue 2015-2018
- AstraZeneca's revenue fom top product Crestor from 2006 to 2018 (in million U.S. dollars)AstraZeneca's revenue from top product Crestor 2006-2018
- Top generic drugs based on savings in the United States in 2018 (in million U.S. dollars)Total savings of top generic drugs in U.S. 2018
- AstraZeneca's revenue from top product Nexium from 2006 to 2018 (in million U.S. dollars)AstraZeneca's revenue from top product Nexium 2006-2018
- Sales growth of leading brands of antacid tablets in the United States in 2018 (change to prior sales year)Sales growth of leading antacid tablet brands in the U.S. 2018
- Dollar sales share of the leading antacid tablet brands in the United States in 2018*U.S. dollar sales share of the leading antacid tablet brands 2018
- Drug prices and consumer behavior
The most important statistics
- Price disparities for top pharmaceutical product Nexium in the U.S. and abroad as of 2017 (in U.S. dollars per pill)*Price disparities for top product Nexium - U.S. and international 2017
- Esomeprazole out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*Esomeprazole out of pocket cost U.S. 2004-2016
- Price disparities for pharmaceutical product Crestor in the U.S. and abroad as of 2017 (in U.S. dollars per pill)*Price disparities for top product Crestor - U.S. and international 2017
- Rosuvastatin calcium out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*Rosuvastatin calcium out-of-pocket cost U.S. 2004-2016
- Advertising expenditures
The most important statistics
- AstraZeneca advertising spending in the United States from 2012 to 2018 (in million U.S. dollars)AstraZeneca: ad spend in the U.S. 2012-2018
- Leading pharmaceutical companies in the United States in 2017, by direct to consumer spending (in million U.S. dollars)Leading pharmaceutical companies in the U.S. 2017, by DTC
- Leading pharmaceutical companies in the United States between January and august 2019, by professional health print journals ad spend (in million U.S. dollars)Pharma companies with largest print ad spend in the U.S. 2019
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- AstraZeneca's revenue 2013-2018 by region
- AstraZeneca's employees by region 2018
- AstraZeneca's expenditure on research and development 2006-2018
- AstraZeneca's operating profit 2006-2018
- AstraZeneca's revenue by therapeutic area 2015-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2018
- AstraZeneca - number of animals used for research purposes 2006-2018
- AstraZeneca's R&D expenditure as a percentage of revenue 2006-2018
- AstraZeneca's revenue from top product Seroquel 2006-2018
- AstraZeneca - ad spend in the U.S. 2014, by medium
- GlaxoSmithKline's revenue 2006-2018
- Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by location
- Price disparities for Spiriva Handihaler - U.S. and international 2017
- Total worldwide prescription drug revenue - projection 2018-2024
- Prescription spending per capita for U.S. under 26-agers by insurance 2010-2020
- Luxembourg: number of pharmaceutical preparations manufacturers 2008-2016
- Share of revenue of Aurobindo Pharma Limited in India FY 2018, by type
- Forecasted global polyethylene demand by region 2022
- Arvato's revenue from 2005 to 2018
Studies
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in Italy
- Pharmaceutical trends in Europe
- Biotechnology in Germany
- PAGB Annual Review 2017-2018
- Teva - 2018 Form 10-K
- Indicatori Farmaceutici
- Novo Nordisk ANNUAL REPORT 2017
- Generic Pharmaceutical Industry Yearbook 2016
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2006 to 2013
Statistics on "Pharmaceutical brands: Crestor and Nexium (AstraZeneca)"
- Top pharmaceutical products by sales worldwide 2018
- AstraZeneca's top products based on revenue 2015-2018
- AstraZeneca's revenue from top product Crestor 2006-2018
- Total savings of top generic drugs in U.S. 2018
- AstraZeneca's revenue from top product Nexium 2006-2018
- Sales growth of leading antacid tablet brands in the U.S. 2018
- U.S. dollar sales share of the leading antacid tablet brands 2018
- Price disparities for top product Nexium - U.S. and international 2017
- Esomeprazole out of pocket cost U.S. 2004-2016
- Price disparities for top product Crestor - U.S. and international 2017
- Rosuvastatin calcium out-of-pocket cost U.S. 2004-2016
- AstraZeneca: ad spend in the U.S. 2012-2018
- Leading pharmaceutical companies in the U.S. 2017, by DTC
- Pharma companies with largest print ad spend in the U.S. 2019
- AstraZeneca's revenue 2013-2018 by region
- AstraZeneca's employees by region 2018
- AstraZeneca's expenditure on research and development 2006-2018
- AstraZeneca's operating profit 2006-2018
- AstraZeneca's revenue by therapeutic area 2015-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2018
- AstraZeneca - number of animals used for research purposes 2006-2018
- AstraZeneca's R&D expenditure as a percentage of revenue 2006-2018
- AstraZeneca's revenue from top product Seroquel 2006-2018
- AstraZeneca - ad spend in the U.S. 2014, by medium
- GlaxoSmithKline's revenue 2006-2018
- Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by location
- Price disparities for Spiriva Handihaler - U.S. and international 2017
- Total worldwide prescription drug revenue - projection 2018-2024
- Prescription spending per capita for U.S. under 26-agers by insurance 2010-2020
- Luxembourg: number of pharmaceutical preparations manufacturers 2008-2016
- Share of revenue of Aurobindo Pharma Limited in India FY 2018, by type
- Forecasted global polyethylene demand by region 2022
- Arvato's revenue from 2005 to 2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.